Press "Enter" to skip to content

Study shows PICS as bioequivalent to Abraxane to treat breast cancer: SPARC

Paclitaxel injection concentrate for suspension (PICS) is a novel formulation of Paclitaxel developed using SPARC’s proprietary Nanotecton technology.

Original source: https://health.economictimes.indiatimes.com/news/pharma/study-shows-pics-as-bioequivalent-to-abraxane-to-treat-breast-cancer-sparc/66810932?utm_source=RSS&utm_medium=ETRSS

Also Read:   U.S. may convert thousands of New York hotel, college rooms into care units